Trials / Completed
CompletedNCT00866216
Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting Conditions
Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Geneva 600mg Azithromycin Monohydrate Tablets and Pfizer Inc. (Zithromax) 600mg Azithromycin Dihydrate Tablets in Healthy Adult Volunteers Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to demonstrate the bioequivalence of Azithromycin Monohydrate 600 mg Tablets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin Monohydrate 600mg Tablets Geneva Pharmaceuticals | |
| DRUG | Zithromax (Azithromycin Dihydrate) 600mg Tablets Pfizer Inc. |
Timeline
- Start date
- 2003-08-01
- Primary completion
- 2003-09-01
- Completion
- 2003-09-01
- First posted
- 2009-03-20
- Last updated
- 2017-03-29
Source: ClinicalTrials.gov record NCT00866216. Inclusion in this directory is not an endorsement.